Scotiabank Forecasts Strong Price Appreciation for Travere Therapeutics (NASDAQ:TVTX) Stock
Travere Therapeutics (NASDAQ:TVTX – Free Report) had its price target boosted by Scotiabank from $27.00 to $32.00 in a research report released on Wednesday,Benzinga reports. Scotiabank currently has a sector outperform rating on the stock. A number of other analysts have also commented on TVTX. Evercore ISI lifted their target price on Travere Therapeutics from […]
Travere Therapeutics (NASDAQ:TVTX – Free Report) had its price target boosted by Scotiabank from $27.00 to $32.00 in a research report released on Wednesday,Benzinga reports. Scotiabank currently has a sector outperform rating on the stock. A number of other analysts have also commented on TVTX. Evercore ISI lifted their target price on Travere Therapeutics from […]
